REPROCELL USA Receives Maryland Stem Cell Research Fund Grant for New CDMO
REPROCELL USA has received funding from the Maryland Stem Cell Research Fund (MSCRF) through the Manufacturing Assistance Grant Program, announced in a press release. The grant, part of MSCRF’s July 2025 funding cycle, supports the establishment of a Contract Development and Manufacturing Organization (CDMO) in Maryland.
The project, titled “Development of a Centralized (GMP) Contract Development and Manufacturing Organization (CDMO) and iGRP manufacturing,” will include a clean room for large-scale GMP-grade cell therapy product production. This facility will enable REPROCELL to provide two GMP technologies under one roof.
The new CDMO will expand REPROCELL’s capacity to produce working cell banks for cell therapy products, GMP-grade differentiation, gene editing services, and large-scale mesenchymal stem cells (MSC) generated from human induced pluripotent stem cells (hiPSC). The funding is structured as a 1:1 match, with REPROCELL matching the MSCRF contribution dollar for dollar.
In 2024, MSCRF also provided a grant to enhance REPROCELL’s Cytocentric Xvivo System Model 2 from BioSpherix, a closed GMP system for master cell bank manufacturing.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Nov 13 Bracco and Avicenna.AI win FDA clearance for AI that flags brain aneurysms on CT scans Nov 13 Zus Health raises $33 million to build the data layer for healthcare AI Nov 13 Google DeepMind releases AlphaGenome 2 to predict DNA variant effects in specific cell types Nov 13 Taiwan hospital accelerator T+ MedIC names AI ECG and CT screening tools as first winners Nov 13 Sheinbaum meets OpenAI president Greg Brockman on AI in Mexican healthcareLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
Formation Bio Forms $600 Million Drug Development Fund
INmune Bio and QCi Apply Quantum Computing to XPro Research
Flagship Pioneering Merges Three Biotech Platforms Into Etcelera
Biomatter Raises $18 Million for AI Enzyme Design
Araceli Biosciences Adds Investor to $4.5 Million Round
Daily AI Brief: the AI news that matters, in your inbox.